Its role as an independent negative prognostic factor in patients with lymphoma has been confirmed by El Far et al. [58], and Lai et al. reported that IL-6 may be a prognostic marker in patients with Hodgkin disease or B-chronic lymphocytic leukemia [59]. The gene discussed is IL6; the disease is B-cell chronic lymphocytic leukemia.